Press Releases

Appendix 4C Quarterly Report Quarter ended 30 June 2014

GI Dynamics to Hold Briefing Call and Webcast on Financial Results for Second Quarter 2014 on Monday, 4 August 2014 at 6 p.m. U.S. EDT  / Tuesday, 5 August 2014 at 8 a.m. AEST     LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 31 July 2014 – GI Dynamics, Inc. (ASX: GID) (GI...

read more

GI Dynamics Announces Departure of Chief Commercial Officer

Company Provides Preliminary Update on Second Quarter Revenues LEXINGTON, MA, United States and SYDNEY, Australia – 1 JULY 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, announced that Mark C. Twyman is leaving his...

read more

Data Presented at ADA Show the Effects of GI Dynamics’ EndoBarrier® Therapy on Glycemic Control and Reducing Diabetes Medication in Patients with Type 2 Diabetes and Obesity

Data Presented at the Scientific Sessions of the American Diabetes Association Demonstrate Increased Bile Acids Levels Following EndoBarrier Therapy; Further Establishes Potential Mechanism of Action SAN FRANCISCO, United States and SYDNEY, Australia – 16 June 2014 – GI Dynamics, Inc. (ASX: GID),...

read more
Page 10 of 21« First...89101112...20...Last »